Treatments & Interventions
Imipramine hydrochloride
substance
Imipramine pamoate
substance
Desipramine hydrochloride
substance
Nortriptyline hydrochloride
substance
Methylphenidate hydrochloride
substance
Dexamphetamine sulfate
substance
Amphetamine sulfate
substance
Venlafaxine hydrochloride
substance
Selegiline hydrochloride
substance
Guanfacine hydrochloride
substance
Amphetamine aspartate
substance
Venlafaxine
substance
Selegiline
substance
Guanfacine
substance
Nortriptyline
substance
Desipramine
substance
Imipramine
substance
Clonidine
substance
Methylphenidate
substance
Dexmethylphenidate hydrochloride
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 406506008
- UMLS CUI
- C1263846
- Fully Specified Name
- Attention deficit hyperactivity disorder (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 2
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.